ApoE facilitates the microglial response to amyloid plaque pathology

One of the hallmarks of Alzheimer's disease is the presence of extracellular diffuse and fibrillar plaques predominantly consisting of the amyloid-β (Aβ) peptide. Apolipoprotein E (ApoE) influences the deposition of amyloid pathology through affecting the clearance and aggregation of monomeric...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of experimental medicine Vol. 215; no. 4; pp. 1047 - 1058
Main Authors Ulrich, Jason D, Ulland, Tyler K, Mahan, Thomas E, Nyström, Sofie, Nilsson, K Peter, Song, Wilbur M, Zhou, Yingyue, Reinartz, Mariska, Choi, Seulah, Jiang, Hong, Stewart, Floy R, Anderson, Elise, Wang, Yaming, Colonna, Marco, Holtzman, David M
Format Journal Article
LanguageEnglish
Published United States Rockefeller University Press 02.04.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract One of the hallmarks of Alzheimer's disease is the presence of extracellular diffuse and fibrillar plaques predominantly consisting of the amyloid-β (Aβ) peptide. Apolipoprotein E (ApoE) influences the deposition of amyloid pathology through affecting the clearance and aggregation of monomeric Aβ in the brain. In addition to influencing Aβ metabolism, increasing evidence suggests that apoE influences microglial function in neurodegenerative diseases. Here, we characterize the impact that apoE has on amyloid pathology and the innate immune response in APPPS1ΔE9 and APPPS1-21 transgenic mice. We report that deficiency reduced fibrillar plaque deposition, consistent with previous studies. However, fibrillar plaques in -deficient mice exhibited a striking reduction in plaque compaction. Hyperspectral fluorescent imaging using luminescent conjugated oligothiophenes identified distinct Aβ morphotypes in -deficient mice. We also observed a significant reduction in fibrillar plaque-associated microgliosis and activated microglial gene expression in -deficient mice, along with significant increases in dystrophic neurites around fibrillar plaques. Our results suggest that apoE is critical in stimulating the innate immune response to amyloid pathology.
AbstractList One of the hallmarks of Alzheimer’s disease is the presence of extracellular diffuse and fibrillar plaques predominantly consisting of the amyloid-β (Aβ) peptide. Apolipoprotein E (ApoE) influences the deposition of amyloid pathology through affecting the clearance and aggregation of monomeric Aβ in the brain. In addition to influencing Aβ metabolism, increasing evidence suggests that apoE influences microglial function in neurodegenerative diseases. Here, we characterize the impact that apoE has on amyloid pathology and the innate immune response in APPPS1ΔE9 and APPPS1-21 transgenic mice. We report that Apoe deficiency reduced fibrillar plaque deposition, consistent with previous studies. However, fibrillar plaques in Apoe-deficient mice exhibited a striking reduction in plaque compaction. Hyperspectral fluorescent imaging using luminescent conjugated oligothiophenes identified distinct Aβ morphotypes in Apoe-deficient mice. We also observed a significant reduction in fibrillar plaque–associated microgliosis and activated microglial gene expression in Apoe-deficient mice, along with significant increases in dystrophic neurites around fibrillar plaques. Our results suggest that apoE is critical in stimulating the innate immune response to amyloid pathology.
Increasing evidence suggests that apoE influences the innate immune response in neurodegeneration. Here, Ulrich et al. report that apoE influences amyloid plaque morphology and the microglial response to amyloid plaques, along with plaque-associated neuronal toxicity.One of the hallmarks of Alzheimer’s disease is the presence of extracellular diffuse and fibrillar plaques predominantly consisting of the amyloid-β (Aβ) peptide. Apolipoprotein E (ApoE) influences the deposition of amyloid pathology through affecting the clearance and aggregation of monomeric Aβ in the brain. In addition to influencing Aβ metabolism, increasing evidence suggests that apoE influences microglial function in neurodegenerative diseases. Here, we characterize the impact that apoE has on amyloid pathology and the innate immune response in APPPS1ΔE9 and APPPS1-21 transgenic mice. We report that Apoe deficiency reduced fibrillar plaque deposition, consistent with previous studies. However, fibrillar plaques in Apoe-deficient mice exhibited a striking reduction in plaque compaction. Hyperspectral fluorescent imaging using luminescent conjugated oligothiophenes identified distinct Aβ morphotypes in Apoe-deficient mice. We also observed a significant reduction in fibrillar plaque–associated microgliosis and activated microglial gene expression in Apoe-deficient mice, along with significant increases in dystrophic neurites around fibrillar plaques. Our results suggest that apoE is critical in stimulating the innate immune response to amyloid pathology.
One of the hallmarks of Alzheimer's disease is the presence of extracellular diffuse and fibrillar plaques predominantly consisting of the amyloid-β (Aβ) peptide. Apolipoprotein E (ApoE) influences the deposition of amyloid pathology through affecting the clearance and aggregation of monomeric Aβ in the brain. In addition to influencing Aβ metabolism, increasing evidence suggests that apoE influences microglial function in neurodegenerative diseases. Here, we characterize the impact that apoE has on amyloid pathology and the innate immune response in APPPS1ΔE9 and APPPS1-21 transgenic mice. We report that deficiency reduced fibrillar plaque deposition, consistent with previous studies. However, fibrillar plaques in -deficient mice exhibited a striking reduction in plaque compaction. Hyperspectral fluorescent imaging using luminescent conjugated oligothiophenes identified distinct Aβ morphotypes in -deficient mice. We also observed a significant reduction in fibrillar plaque-associated microgliosis and activated microglial gene expression in -deficient mice, along with significant increases in dystrophic neurites around fibrillar plaques. Our results suggest that apoE is critical in stimulating the innate immune response to amyloid pathology.
Increasing evidence suggests that apoE influences the innate immune response in neurodegeneration. Here, Ulrich et al. report that apoE influences amyloid plaque morphology and the microglial response to amyloid plaques, along with plaque-associated neuronal toxicity. One of the hallmarks of Alzheimer’s disease is the presence of extracellular diffuse and fibrillar plaques predominantly consisting of the amyloid-β (Aβ) peptide. Apolipoprotein E (ApoE) influences the deposition of amyloid pathology through affecting the clearance and aggregation of monomeric Aβ in the brain. In addition to influencing Aβ metabolism, increasing evidence suggests that apoE influences microglial function in neurodegenerative diseases. Here, we characterize the impact that apoE has on amyloid pathology and the innate immune response in APPPS1ΔE9 and APPPS1-21 transgenic mice. We report that Apoe deficiency reduced fibrillar plaque deposition, consistent with previous studies. However, fibrillar plaques in Apoe -deficient mice exhibited a striking reduction in plaque compaction. Hyperspectral fluorescent imaging using luminescent conjugated oligothiophenes identified distinct Aβ morphotypes in Apoe -deficient mice. We also observed a significant reduction in fibrillar plaque–associated microgliosis and activated microglial gene expression in Apoe -deficient mice, along with significant increases in dystrophic neurites around fibrillar plaques. Our results suggest that apoE is critical in stimulating the innate immune response to amyloid pathology.
One of the hallmarks of Alzheimers disease is the presence of extracellular diffuse and fibrillar plaques predominantly consisting of the amyloid-beta (A beta) peptide. Apolipoprotein E (ApoE) influences the deposition of amyloid pathology through affecting the clearance and aggregation of monomeric A beta in the brain. In addition to influencing A beta metabolism, increasing evidence suggests that apoE influences microglial function in neurodegenerative diseases. Here, we characterize the impact that apoE has on amyloid pathology and the innate immune response in APPPS1 Delta E9 and APPPS1-21 transgenic mice. We report that Apoe deficiency reduced fibrillar plaque deposition, consistent with previous studies. However, fibrillar plaques in Apoe-deficient mice exhibited a striking reduction in plaque compaction. Hyperspectral fluorescent imaging using luminescent conjugated oligothiophenes identified distinct A beta morphotypes in Apoe-deficient mice. We also observed a significant reduction in fibrillar plaque-associated microgliosis and activated microglial gene expression in Apoe-deficient mice, along with significant increases in dystrophic neurites around fibrillar plaques. Our results suggest that apoE is critical in stimulating the innate immune response to amyloid pathology.
Author Song, Wilbur M
Nilsson, K Peter
Anderson, Elise
Jiang, Hong
Nyström, Sofie
Zhou, Yingyue
Ulland, Tyler K
Choi, Seulah
Reinartz, Mariska
Colonna, Marco
Ulrich, Jason D
Wang, Yaming
Mahan, Thomas E
Holtzman, David M
Stewart, Floy R
AuthorAffiliation 1 Department of Neurology, Washington University School of Medicine, St. Louis, MO
2 Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO
3 Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO
4 Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO
5 Department of Chemistry, IFM, Linköping University, Linköping, Sweden
6 Radboud University Nijmegen, Nijmegen, Netherlands
7 Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN
AuthorAffiliation_xml – name: 6 Radboud University Nijmegen, Nijmegen, Netherlands
– name: 7 Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN
– name: 3 Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO
– name: 1 Department of Neurology, Washington University School of Medicine, St. Louis, MO
– name: 5 Department of Chemistry, IFM, Linköping University, Linköping, Sweden
– name: 2 Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO
– name: 4 Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO
Author_xml – sequence: 1
  givenname: Jason D
  surname: Ulrich
  fullname: Ulrich, Jason D
  organization: Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO
– sequence: 2
  givenname: Tyler K
  orcidid: 0000-0002-6507-4989
  surname: Ulland
  fullname: Ulland, Tyler K
  organization: Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO
– sequence: 3
  givenname: Thomas E
  surname: Mahan
  fullname: Mahan, Thomas E
  organization: Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO
– sequence: 4
  givenname: Sofie
  orcidid: 0000-0002-4303-4783
  surname: Nyström
  fullname: Nyström, Sofie
  organization: Department of Chemistry, IFM, Linköping University, Linköping, Sweden
– sequence: 5
  givenname: K Peter
  surname: Nilsson
  fullname: Nilsson, K Peter
  organization: Department of Chemistry, IFM, Linköping University, Linköping, Sweden
– sequence: 6
  givenname: Wilbur M
  orcidid: 0000-0002-6608-4628
  surname: Song
  fullname: Song, Wilbur M
  organization: Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO
– sequence: 7
  givenname: Yingyue
  surname: Zhou
  fullname: Zhou, Yingyue
  organization: Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO
– sequence: 8
  givenname: Mariska
  orcidid: 0000-0001-7964-7963
  surname: Reinartz
  fullname: Reinartz, Mariska
  organization: Radboud University Nijmegen, Nijmegen, Netherlands
– sequence: 9
  givenname: Seulah
  surname: Choi
  fullname: Choi, Seulah
  organization: Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO
– sequence: 10
  givenname: Hong
  surname: Jiang
  fullname: Jiang, Hong
  organization: Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO
– sequence: 11
  givenname: Floy R
  surname: Stewart
  fullname: Stewart, Floy R
  organization: Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO
– sequence: 12
  givenname: Elise
  surname: Anderson
  fullname: Anderson, Elise
  organization: Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO
– sequence: 13
  givenname: Yaming
  surname: Wang
  fullname: Wang, Yaming
  organization: Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN
– sequence: 14
  givenname: Marco
  orcidid: 0000-0001-5222-4987
  surname: Colonna
  fullname: Colonna, Marco
  email: mcolonna@pathology.wustl.edu
  organization: Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO mcolonna@pathology.wustl.edu
– sequence: 15
  givenname: David M
  orcidid: 0000-0002-3400-0856
  surname: Holtzman
  fullname: Holtzman, David M
  email: holtzman@neuro.wustl.edu
  organization: Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29483128$$D View this record in MEDLINE/PubMed
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-150505$$DView record from Swedish Publication Index
BookMark eNpdkTtP5DAUhS3ECoZHR40i0WxB2GvHTuwGacRzJaRtFlrLCTczHjlxsBPQ_Pv1aADByoULf_f4nHsOyG7veyTkhMIFBcl_rbC7YEArykqxQ2ZUcMiVKOQumQEwllOAap8cxLgCoJyLco_sM8VlQZmckev54G-y1jTW2dGMGLNxiVlnm-AXzhqXBYyD7yNmo89Mt3bePmeDMy8TZoMZl975xfqI_GiNi3j8fh-Sx9ubv1f3-cOfu99X84e8EbQcc1Ur5IWqK1UJIZMTxgpOUdRlayTlpULKq9aYGhoKVKm2kRXjlUAjBC_Kujgk-VY3vuEw1XoItjNhrb2x-to-zbUPC-3spKmAdBJ_ueUT3OFzg_0YjPs29v2lt0u98K9ayI0fngR-vgsEnxLHUXc2Nuic6dFPUTMAKaXY_nX2H7ryU-jTOhLFgFcpyoY631JpvzEGbD_NUNCbOnWqU3_UmfDTrwE-4Y_-in9AQpxR
CitedBy_id crossref_primary_10_1186_s13024_018_0303_3
crossref_primary_10_3389_fncel_2021_749587
crossref_primary_10_1016_j_nbd_2019_02_015
crossref_primary_10_2967_jnumed_119_227322
crossref_primary_10_3389_fnins_2024_1326784
crossref_primary_10_1007_s12035_021_02477_9
crossref_primary_10_1177_10738584211040786
crossref_primary_10_3390_ijms23105404
crossref_primary_10_1016_j_neuron_2021_03_024
crossref_primary_10_1515_tjb_2020_0135
crossref_primary_10_1016_j_immuni_2019_03_016
crossref_primary_10_1016_j_neurobiolaging_2024_03_007
crossref_primary_10_1002_cbic_202300044
crossref_primary_10_1146_annurev_genet_112618_043515
crossref_primary_10_1016_j_neuron_2024_01_013
crossref_primary_10_1002_alz_13780
crossref_primary_10_1186_s13024_022_00588_y
crossref_primary_10_3389_fnagi_2022_888989
crossref_primary_10_3389_fnagi_2023_1158579
crossref_primary_10_1016_j_isci_2024_110006
crossref_primary_10_1016_j_jneuroim_2024_578342
crossref_primary_10_1038_s41593_018_0296_9
crossref_primary_10_1186_s13024_019_0337_1
crossref_primary_10_1038_s41577_023_00837_1
crossref_primary_10_1016_j_tins_2022_01_002
crossref_primary_10_1002_alz_13703
crossref_primary_10_3389_fimmu_2020_00754
crossref_primary_10_1007_s11064_018_2629_1
crossref_primary_10_3389_fnins_2018_00963
crossref_primary_10_1016_S1474_4422_20_30412_9
crossref_primary_10_1093_braincomms_fcab126
crossref_primary_10_1038_s41593_024_01669_5
crossref_primary_10_1016_j_jlr_2023_100350
crossref_primary_10_1126_scitranslmed_abc9375
crossref_primary_10_1002_chem_202203568
crossref_primary_10_1093_nar_gkae100
crossref_primary_10_1007_s00401_020_02200_3
crossref_primary_10_1002_glia_24105
crossref_primary_10_1016_j_isci_2023_106375
crossref_primary_10_1016_j_nbas_2022_100055
crossref_primary_10_3390_ph14050458
crossref_primary_10_1016_j_it_2020_07_006
crossref_primary_10_1126_scitranslmed_adj9052
crossref_primary_10_3390_ijms242417377
crossref_primary_10_7554_eLife_54083
crossref_primary_10_3390_ijms22042033
crossref_primary_10_1017_S1431927621012095
crossref_primary_10_3389_fnagi_2023_1201982
crossref_primary_10_1126_sciadv_abk0473
crossref_primary_10_1186_s13024_024_00734_8
crossref_primary_10_1364_OE_390874
crossref_primary_10_3390_biomedicines10040840
crossref_primary_10_1126_scitranslmed_aay3069
crossref_primary_10_1177_1073858420987224
crossref_primary_10_1038_s41593_022_01127_0
crossref_primary_10_1038_s41590_018_0212_1
crossref_primary_10_1016_j_bbalip_2022_159123
crossref_primary_10_1016_j_jconrel_2021_08_018
crossref_primary_10_1093_gerona_glz262
crossref_primary_10_1038_s41582_019_0228_7
crossref_primary_10_3233_JAD_190711
crossref_primary_10_4103_1673_5374_355747
crossref_primary_10_1007_s00018_023_04784_x
crossref_primary_10_1186_s13024_019_0351_3
crossref_primary_10_1093_jnen_nlab085
crossref_primary_10_1016_j_arr_2020_101212
crossref_primary_10_1016_j_celrep_2019_03_099
crossref_primary_10_1186_s12974_023_02823_9
crossref_primary_10_1186_s13024_022_00574_4
crossref_primary_10_1002_jnr_24718
crossref_primary_10_1016_j_ijbiomac_2022_01_115
crossref_primary_10_1038_s43587_021_00054_2
crossref_primary_10_1001_jamanetworkopen_2019_13909
crossref_primary_10_1038_s43587_023_00491_1
crossref_primary_10_3389_fnagi_2018_00395
crossref_primary_10_1186_s40478_019_0840_1
crossref_primary_10_3390_ijms241310809
crossref_primary_10_1016_j_neuron_2022_10_022
crossref_primary_10_1016_j_neuron_2022_10_021
crossref_primary_10_2967_jnumed_120_261858
crossref_primary_10_1186_s13195_023_01209_6
crossref_primary_10_1016_j_nicl_2019_101767
crossref_primary_10_1186_s13024_023_00610_x
crossref_primary_10_1177_10738584211070273
crossref_primary_10_3390_biom10101439
crossref_primary_10_1002_alz_12375
crossref_primary_10_1016_j_neulet_2019_134285
crossref_primary_10_1002_JLB_MR0818_319R
crossref_primary_10_1002_alz_12256
crossref_primary_10_1038_s41577_018_0051_1
crossref_primary_10_3390_genes12081247
crossref_primary_10_1016_j_cell_2020_05_003
crossref_primary_10_1084_jem_20200474
crossref_primary_10_1186_s13024_022_00566_4
crossref_primary_10_1016_j_cell_2019_09_001
crossref_primary_10_1186_s13024_020_00413_4
crossref_primary_10_3389_fncel_2018_00397
crossref_primary_10_1007_s12035_022_03082_0
crossref_primary_10_1002_ibra_12155
crossref_primary_10_1186_s12974_020_01948_5
crossref_primary_10_1073_pnas_2218915120
crossref_primary_10_3390_ijms20010081
crossref_primary_10_1016_j_nbd_2022_105967
crossref_primary_10_1177_20406223221081605
crossref_primary_10_1186_s13024_018_0296_y
crossref_primary_10_1007_s12035_024_04143_2
crossref_primary_10_3389_fnins_2021_778822
crossref_primary_10_3390_cells9071717
crossref_primary_10_3389_fnins_2021_666958
crossref_primary_10_1186_s40478_021_01298_0
crossref_primary_10_15252_emmm_201910606
crossref_primary_10_2147_ITT_S455881
crossref_primary_10_2174_1567205017666200212155234
crossref_primary_10_1186_s13024_022_00577_1
crossref_primary_10_1016_j_neurobiolaging_2018_11_008
crossref_primary_10_1186_s13024_022_00516_0
crossref_primary_10_3390_ijms21072381
crossref_primary_10_1111_imr_12896
crossref_primary_10_1016_j_neuroscience_2023_01_032
crossref_primary_10_1038_s43587_021_00123_6
crossref_primary_10_1186_s13024_023_00599_3
crossref_primary_10_1186_s40478_019_0729_z
crossref_primary_10_1038_s41467_024_48484_x
crossref_primary_10_1016_j_apsb_2021_10_002
crossref_primary_10_1016_j_immuni_2022_10_016
crossref_primary_10_1084_jem_20180653
crossref_primary_10_1186_s13024_023_00679_4
crossref_primary_10_3389_fphar_2019_00840
crossref_primary_10_1080_17460441_2020_1674808
crossref_primary_10_1007_s00018_021_03810_0
crossref_primary_10_3389_fneur_2018_01062
crossref_primary_10_1016_j_saa_2023_123743
crossref_primary_10_1038_s41591_018_0336_8
crossref_primary_10_1016_j_neulet_2019_134306
crossref_primary_10_1084_jem_20212479
crossref_primary_10_1016_j_celrep_2020_107530
crossref_primary_10_1016_j_ejphar_2021_173873
crossref_primary_10_1016_j_biopha_2022_114127
crossref_primary_10_3389_fncel_2019_00063
crossref_primary_10_1016_j_neuron_2022_03_004
crossref_primary_10_1186_s40478_020_01075_5
crossref_primary_10_1016_j_pbiomolbio_2023_06_002
crossref_primary_10_1111_nan_12529
crossref_primary_10_1186_s40478_021_01261_z
crossref_primary_10_1172_JCI131564
crossref_primary_10_1002_adma_201806701
crossref_primary_10_1002_chem_202201557
crossref_primary_10_1016_j_smim_2022_101594
crossref_primary_10_1038_s41590_023_01640_9
crossref_primary_10_3390_cells10040957
crossref_primary_10_1002_anbr_202100097
crossref_primary_10_1186_s12864_022_08417_8
crossref_primary_10_1186_s13024_023_00645_0
crossref_primary_10_3389_fnmol_2020_609073
crossref_primary_10_1016_j_it_2024_03_007
crossref_primary_10_1007_s00018_021_03986_5
crossref_primary_10_1186_s13024_018_0298_9
crossref_primary_10_1007_s00401_022_02467_8
crossref_primary_10_2174_1574885518666230427100702
crossref_primary_10_3390_ijms25063090
crossref_primary_10_1002_jnr_24526
crossref_primary_10_1016_j_neurobiolaging_2022_03_011
crossref_primary_10_1016_j_neuron_2020_10_008
crossref_primary_10_3233_JAD_240042
crossref_primary_10_1038_s41551_022_00906_1
crossref_primary_10_1073_pnas_2114486119
crossref_primary_10_3233_JAD_231210
crossref_primary_10_1111_jnc_14674
crossref_primary_10_3233_JAD_230002
Cites_doi 10.1002/cbic.201200731
10.1038/nature11087
10.1038/ncomms7176
10.1038/nn.3697
10.1177/002215540004800906
10.1172/JCI36663
10.1126/science.1227901
10.1016/j.neuron.2017.11.014
10.1038/nature24016
10.1038/sj.jcbfm.9600419
10.1097/NEN.0b013e3182933788
10.1016/j.biopsych.2017.03.003
10.1016/j.cell.2017.05.018
10.1038/ncomms11295
10.1172/JCI6179
10.1039/c1ob05637a
10.1186/1742-2094-11-111
10.1002/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8
10.1152/ajpcell.00563.2005
10.1186/1750-1326-9-20
10.1074/jbc.M115.679043
10.1016/j.cell.2017.07.023
10.1371/journal.pone.0021880
10.1038/ng.801
10.1093/hmg/ddh019
10.1016/j.neuron.2013.04.014
10.1016/j.jalz.2016.07.004
10.1073/pnas.96.26.15233
10.1038/sj.embor.7400784
10.1016/j.immuni.2017.08.008
10.1534/genetics.105.051912
10.1016/j.cell.2015.01.049
10.1056/NEJMoa1211851
10.1021/cb4000376
10.1016/j.jneuroim.2014.03.010
10.1073/pnas.1609896113
10.1038/nn.3599
10.1016/0165-5728(93)90027-V
10.1126/science.294.5545.1354
10.1038/nn.4018
10.1038/ni.3102
10.1038/ng1197-263
10.1016/j.neuron.2017.11.013
10.1016/j.neuron.2016.06.015
10.1016/0304-3940(95)11763-M
10.4161/pri.29239
10.1056/NEJMoa1211103
10.1038/nm.3913
10.1007/s004010000263
10.1006/nbdi.2002.0483
10.1016/j.neuron.2016.05.003
10.1002/ana.24304
10.4049/jimmunol.173.10.6366
10.1523/JNEUROSCI.2110-16.2016
10.1084/jem.20151948
10.1194/jlr.R075481
ContentType Journal Article
Copyright 2018 Ulrich et al.
Copyright Rockefeller University Press Apr 2, 2018
2018 Ulrich et al. 2018
Copyright_xml – notice: 2018 Ulrich et al.
– notice: Copyright Rockefeller University Press Apr 2, 2018
– notice: 2018 Ulrich et al. 2018
DBID NPM
AAYXX
CITATION
7QL
7QP
7T5
7TK
7U9
8FD
C1K
FR3
H94
M7N
P64
RC3
7X8
5PM
ABXSW
ADTPV
AOWAS
D8T
DG8
ZZAVC
DOI 10.1084/jem.20171265
DatabaseName PubMed
CrossRef
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Immunology Abstracts
Neurosciences Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
SWEPUB Linköpings universitet full text
SwePub
SwePub Articles
SWEPUB Freely available online
SWEPUB Linköpings universitet
SwePub Articles full text
DatabaseTitle PubMed
CrossRef
Genetics Abstracts
Virology and AIDS Abstracts
Technology Research Database
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
Immunology Abstracts
Engineering Research Database
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList CrossRef
Genetics Abstracts
PubMed


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate ApoE and microglia activation in amyloid models
EISSN 1540-9538
EndPage 1058
ExternalDocumentID oai_DiVA_org_liu_150505
10_1084_jem_20171265
29483128
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIA NIH HHS
  grantid: R01 AG047644
– fundername: NIA NIH HHS
  grantid: RF1 AG051485
– fundername: NCI NIH HHS
  grantid: T32 CA009547
– fundername: ;
– fundername: Donors Cure Foundation
  grantid: CCAD201703
– fundername: ;
  grantid: 5-T32CA009547-30
– fundername: ;
  grantid: AG047644
– fundername: ;
  grantid: RF1AG05148501
GroupedDBID ---
-~X
18M
29K
2WC
36B
4.4
53G
5GY
5RE
5VS
ABOCM
ABZEH
ACGFO
ACNCT
ACPRK
ADBBV
AENEX
AFOSN
AFRAH
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
C45
CS3
D-I
DIK
DU5
E3Z
EBS
EJD
F5P
F9R
FRP
GX1
H13
HYE
IH2
K-O
KQ8
L7B
N9A
NPM
O5R
O5S
OK1
P2P
P6G
R.V
RHF
RHI
RPM
SJN
TR2
TRP
UHB
W8F
WOQ
AAYXX
CITATION
7QL
7QP
7T5
7TK
7U9
8FD
C1K
EMB
FR3
H94
M7N
P64
RC3
7X8
5PM
.55
.GJ
0VX
3O-
9M8
ABXSW
ADTPV
AFFNX
AI.
AOWAS
D8T
DG8
EMOBN
H~9
MK0
MVM
N4W
OHT
OVD
SV3
VH1
X7M
ZGI
ZZAVC
ID FETCH-LOGICAL-c516t-9b9e439b79755845622341e5b6fa81469e147faab0c10199fc872475ea55436b3
IEDL.DBID RPM
ISSN 0022-1007
1540-9538
IngestDate Sat Aug 24 00:47:17 EDT 2024
Tue Sep 17 21:23:53 EDT 2024
Sat Aug 17 00:10:46 EDT 2024
Wed Sep 25 02:46:27 EDT 2024
Fri Aug 23 00:56:37 EDT 2024
Tue Aug 27 13:46:23 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
License 2018 Ulrich et al.
This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c516t-9b9e439b79755845622341e5b6fa81469e147faab0c10199fc872475ea55436b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
J.D. Ulrich, T.K. Ulland, and T.E. Mahan contributed equally to this paper.
ORCID 0000-0002-4303-4783
0000-0001-7964-7963
0000-0001-5222-4987
0000-0002-6608-4628
0000-0002-3400-0856
0000-0002-6507-4989
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881464/
PMID 29483128
PQID 2020477245
PQPubID 2046203
PageCount 12
ParticipantIDs swepub_primary_oai_DiVA_org_liu_150505
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5881464
proquest_miscellaneous_2008885505
proquest_journals_2020477245
crossref_primary_10_1084_jem_20171265
pubmed_primary_29483128
PublicationCentury 2000
PublicationDate 20180402
PublicationDateYYYYMMDD 2018-04-02
PublicationDate_xml – month: 4
  year: 2018
  text: 20180402
  day: 2
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: New York
PublicationTitle The Journal of experimental medicine
PublicationTitleAlternate J Exp Med
PublicationYear 2018
Publisher Rockefeller University Press
Publisher_xml – name: Rockefeller University Press
References Wang (2023072604113442000_bib52) 2016; 213
Gutierrez (2023072604113442000_bib16) 1993; 47
Saito (2023072604113442000_bib40) 2014; 17
Serrano-Pozo (2023072604113442000_bib41) 2013; 72
Ulland (2023072604113442000_bib49) 2017; 170
Bales (2023072604113442000_bib4) 1999; 96
Jankowsky (2023072604113442000_bib24) 2004; 13
Uchihara (2023072604113442000_bib48) 1995; 195
Bell (2023072604113442000_bib6) 2012; 485
Zhao (2023072604113442000_bib56) 2018; 83
Liu (2023072604113442000_bib32) 2017; 96
Radde (2023072604113442000_bib38) 2006; 7
Grainger (2023072604113442000_bib13) 2004; 173
Magnusson (2023072604113442000_bib33) 2014; 8
Aguzzi (2023072604113442000_bib1) 2013; 339
Zhou (2023072604113442000_bib57) 1996; 149
Shi (2023072604113442000_bib42) 2017; 549
Butovsky (2023072604113442000_bib7) 2014; 17
Nyström (2023072604113442000_bib37) 2013; 8
Song (2023072604113442000_bib44) 2017; 13
Butovsky (2023072604113442000_bib8) 2015; 77
Jonsson (2023072604113442000_bib26) 2013; 368
Mauch (2023072604113442000_bib34) 2001; 294
Katsouri (2023072604113442000_bib27) 2011; 6
Jay (2023072604113442000_bib25) 2017; 37
Holtzman (2023072604113442000_bib19) 1999; 103
Yeh (2023072604113442000_bib53) 2016; 91
Bell (2023072604113442000_bib5) 2007; 27
Hafezi-Moghadam (2023072604113442000_bib17) 2007; 292
Holtzman (2023072604113442000_bib20) 2000; 47
Krasemann (2023072604113442000_bib31) 2017; 47
Bales (2023072604113442000_bib3) 1997; 17
Rodriguez (2023072604113442000_bib39) 2014; 11
Fagan (2023072604113442000_bib12) 2002; 9
Su (2023072604113442000_bib47) 2006; 172
Yuan (2023072604113442000_bib54) 2016; 90
Zenaro (2023072604113442000_bib55) 2015; 21
Klingstedt (2023072604113442000_bib30) 2013; 14
Keren-Shaul (2023072604113442000_bib28) 2017; 169
Huynh (2023072604113442000_bib22) 2017; 96
Griciuc (2023072604113442000_bib14) 2013; 78
Shin (2023072604113442000_bib43) 2014; 271
Chung (2023072604113442000_bib9) 2016; 113
Huynh (2023072604113442000_bib21) 2017; 58
Deane (2023072604113442000_bib11) 2008; 118
Guerreiro (2023072604113442000_bib15) 2013; 368
Atagi (2023072604113442000_bib2) 2015; 290
Irizarry (2023072604113442000_bib23) 2000; 100
Ulrich (2023072604113442000_bib50) 2014; 9
Heneka (2023072604113442000_bib18) 2015; 16
Condello (2023072604113442000_bib10) 2015; 6
Naj (2023072604113442000_bib36) 2011; 43
Musiek (2023072604113442000_bib35) 2015; 18
Klingstedt (2023072604113442000_bib29) 2011; 9
Styren (2023072604113442000_bib46) 2000; 48
Srinivasan (2023072604113442000_bib45) 2016; 7
Wang (2023072604113442000_bib51) 2015; 160
References_xml – volume: 14
  start-page: 607
  year: 2013
  ident: 2023072604113442000_bib30
  article-title: Luminescent conjugated oligothiophenes for sensitive fluorescent assignment of protein inclusion bodies
  publication-title: ChemBioChem.
  doi: 10.1002/cbic.201200731
  contributor:
    fullname: Klingstedt
– volume: 485
  start-page: 512
  year: 2012
  ident: 2023072604113442000_bib6
  article-title: Apolipoprotein E controls cerebrovascular integrity via cyclophilin A
  publication-title: Nature.
  doi: 10.1038/nature11087
  contributor:
    fullname: Bell
– volume: 6
  start-page: 6176
  year: 2015
  ident: 2023072604113442000_bib10
  article-title: Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms7176
  contributor:
    fullname: Condello
– volume: 17
  start-page: 661
  year: 2014
  ident: 2023072604113442000_bib40
  article-title: Single App knock-in mouse models of Alzheimer’s disease
  publication-title: Nat. Neurosci.
  doi: 10.1038/nn.3697
  contributor:
    fullname: Saito
– volume: 48
  start-page: 1223
  year: 2000
  ident: 2023072604113442000_bib46
  article-title: X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer’s disease pathology
  publication-title: J. Histochem. Cytochem.
  doi: 10.1177/002215540004800906
  contributor:
    fullname: Styren
– volume: 118
  start-page: 4002
  year: 2008
  ident: 2023072604113442000_bib11
  article-title: apoE isoform-specific disruption of amyloid β peptide clearance from mouse brain
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI36663
  contributor:
    fullname: Deane
– volume: 339
  start-page: 156
  year: 2013
  ident: 2023072604113442000_bib1
  article-title: Microglia: scapegoat, saboteur, or something else?
  publication-title: Science.
  doi: 10.1126/science.1227901
  contributor:
    fullname: Aguzzi
– volume: 96
  start-page: 1013
  year: 2017
  ident: 2023072604113442000_bib22
  article-title: Age-Dependent Effects of apoE Reduction Using Antisense Oligonucleotides in a Model of β-amyloidosis
  publication-title: Neuron.
  doi: 10.1016/j.neuron.2017.11.014
  contributor:
    fullname: Huynh
– volume: 549
  start-page: 523
  year: 2017
  ident: 2023072604113442000_bib42
  article-title: ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy
  publication-title: Nature.
  doi: 10.1038/nature24016
  contributor:
    fullname: Shi
– volume: 27
  start-page: 909
  year: 2007
  ident: 2023072604113442000_bib5
  article-title: Transport pathways for clearance of human Alzheimer’s amyloid β-peptide and apolipoproteins E and J in the mouse central nervous system
  publication-title: J. Cereb. Blood Flow Metab.
  doi: 10.1038/sj.jcbfm.9600419
  contributor:
    fullname: Bell
– volume: 72
  start-page: 462
  year: 2013
  ident: 2023072604113442000_bib41
  article-title: Differential relationships of reactive astrocytes and microglia to fibrillar amyloid deposits in Alzheimer disease
  publication-title: J. Neuropathol. Exp. Neurol.
  doi: 10.1097/NEN.0b013e3182933788
  contributor:
    fullname: Serrano-Pozo
– volume: 83
  start-page: 347
  year: 2018
  ident: 2023072604113442000_bib56
  article-title: Apolipoprotein E, Receptors, and Modulation of Alzheimer’s Disease
  publication-title: Biol. Psychiatry.
  doi: 10.1016/j.biopsych.2017.03.003
  contributor:
    fullname: Zhao
– volume: 169
  start-page: 1276
  year: 2017
  ident: 2023072604113442000_bib28
  article-title: A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
  publication-title: Cell.
  doi: 10.1016/j.cell.2017.05.018
  contributor:
    fullname: Keren-Shaul
– volume: 7
  start-page: 11295
  year: 2016
  ident: 2023072604113442000_bib45
  article-title: Untangling the brain’s neuroinflammatory and neurodegenerative transcriptional responses
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms11295
  contributor:
    fullname: Srinivasan
– volume: 103
  start-page: R15
  year: 1999
  ident: 2023072604113442000_bib19
  article-title: Expression of human apolipoprotein E reduces amyloid-β deposition in a mouse model of Alzheimer’s disease
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI6179
  contributor:
    fullname: Holtzman
– volume: 9
  start-page: 8356
  year: 2011
  ident: 2023072604113442000_bib29
  article-title: Synthesis of a library of oligothiophenes and their utilization as fluorescent ligands for spectral assignment of protein aggregates
  publication-title: Org. Biomol. Chem.
  doi: 10.1039/c1ob05637a
  contributor:
    fullname: Klingstedt
– volume: 11
  start-page: 111
  year: 2014
  ident: 2023072604113442000_bib39
  article-title: Human APOE4 increases microglia reactivity at Aβ plaques in a mouse model of Aβ deposition
  publication-title: J. Neuroinflammation.
  doi: 10.1186/1742-2094-11-111
  contributor:
    fullname: Rodriguez
– volume: 47
  start-page: 739
  year: 2000
  ident: 2023072604113442000_bib20
  article-title: Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer’s disease model
  publication-title: Ann. Neurol.
  doi: 10.1002/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8
  contributor:
    fullname: Holtzman
– volume: 292
  start-page: C1256
  year: 2007
  ident: 2023072604113442000_bib17
  article-title: ApoE deficiency leads to a progressive age-dependent blood-brain barrier leakage
  publication-title: Am. J. Physiol. Cell Physiol.
  doi: 10.1152/ajpcell.00563.2005
  contributor:
    fullname: Hafezi-Moghadam
– volume: 9
  start-page: 20
  year: 2014
  ident: 2023072604113442000_bib50
  article-title: Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2
  publication-title: Mol. Neurodegener.
  doi: 10.1186/1750-1326-9-20
  contributor:
    fullname: Ulrich
– volume: 290
  start-page: 26043
  year: 2015
  ident: 2023072604113442000_bib2
  article-title: Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M115.679043
  contributor:
    fullname: Atagi
– volume: 170
  start-page: 649
  year: 2017
  ident: 2023072604113442000_bib49
  article-title: TREM2 Maintains Microglial Metabolic Fitness in Alzheimer’s Disease
  publication-title: Cell
  doi: 10.1016/j.cell.2017.07.023
  contributor:
    fullname: Ulland
– volume: 6
  start-page: e21880
  year: 2011
  ident: 2023072604113442000_bib27
  article-title: Lack of LDL receptor enhances amyloid deposition and decreases glial response in an Alzheimer’s disease mouse model
  publication-title: PLoS One.
  doi: 10.1371/journal.pone.0021880
  contributor:
    fullname: Katsouri
– volume: 43
  start-page: 436
  year: 2011
  ident: 2023072604113442000_bib36
  article-title: Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer’s disease
  publication-title: Nat. Genet.
  doi: 10.1038/ng.801
  contributor:
    fullname: Naj
– volume: 13
  start-page: 159
  year: 2004
  ident: 2023072604113442000_bib24
  article-title: Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase
  publication-title: Hum. Mol. Genet.
  doi: 10.1093/hmg/ddh019
  contributor:
    fullname: Jankowsky
– volume: 149
  start-page: 359
  year: 1996
  ident: 2023072604113442000_bib57
  article-title: Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice
  publication-title: Am. J. Pathol.
  contributor:
    fullname: Zhou
– volume: 78
  start-page: 631
  year: 2013
  ident: 2023072604113442000_bib14
  article-title: Alzheimer’s disease risk gene CD33 inhibits microglial uptake of amyloid beta
  publication-title: Neuron.
  doi: 10.1016/j.neuron.2013.04.014
  contributor:
    fullname: Griciuc
– volume: 13
  start-page: 381
  year: 2017
  ident: 2023072604113442000_bib44
  article-title: Alzheimer’s disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activation
  publication-title: Alzheimers Dement.
  doi: 10.1016/j.jalz.2016.07.004
  contributor:
    fullname: Song
– volume: 96
  start-page: 15233
  year: 1999
  ident: 2023072604113442000_bib4
  article-title: Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer’s disease
  publication-title: Proc. Natl. Acad. Sci. USA.
  doi: 10.1073/pnas.96.26.15233
  contributor:
    fullname: Bales
– volume: 7
  start-page: 940
  year: 2006
  ident: 2023072604113442000_bib38
  article-title: Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology
  publication-title: EMBO Rep.
  doi: 10.1038/sj.embor.7400784
  contributor:
    fullname: Radde
– volume: 47
  start-page: 566
  year: 2017
  ident: 2023072604113442000_bib31
  article-title: The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
  publication-title: Immunity.
  doi: 10.1016/j.immuni.2017.08.008
  contributor:
    fullname: Krasemann
– volume: 172
  start-page: 1799
  year: 2006
  ident: 2023072604113442000_bib47
  article-title: Quantitative trait locus analysis of atherosclerosis in an intercross between C57BL/6 and C3H mice carrying the mutant apolipoprotein E gene
  publication-title: Genetics.
  doi: 10.1534/genetics.105.051912
  contributor:
    fullname: Su
– volume: 160
  start-page: 1061
  year: 2015
  ident: 2023072604113442000_bib51
  article-title: TREM2 lipid sensing sustains the microglial response in an Alzheimer’s disease model
  publication-title: Cell.
  doi: 10.1016/j.cell.2015.01.049
  contributor:
    fullname: Wang
– volume: 368
  start-page: 117
  year: 2013
  ident: 2023072604113442000_bib15
  article-title: TREM2 variants in Alzheimer’s disease
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1211851
  contributor:
    fullname: Guerreiro
– volume: 8
  start-page: 1128
  year: 2013
  ident: 2023072604113442000_bib37
  article-title: Evidence for age-dependent in vivo conformational rearrangement within Aβ amyloid deposits
  publication-title: ACS Chem. Biol.
  doi: 10.1021/cb4000376
  contributor:
    fullname: Nyström
– volume: 271
  start-page: 8
  year: 2014
  ident: 2023072604113442000_bib43
  article-title: Apolipoprotein E mediation of neuro-inflammation in a murine model of multiple sclerosis
  publication-title: J. Neuroimmunol.
  doi: 10.1016/j.jneuroim.2014.03.010
  contributor:
    fullname: Shin
– volume: 113
  start-page: 10186
  year: 2016
  ident: 2023072604113442000_bib9
  article-title: Novel allele-dependent role for APOE in controlling the rate of synapse pruning by astrocytes
  publication-title: Proc. Natl. Acad. Sci. USA.
  doi: 10.1073/pnas.1609896113
  contributor:
    fullname: Chung
– volume: 17
  start-page: 131
  year: 2014
  ident: 2023072604113442000_bib7
  article-title: Identification of a unique TGF-β-dependent molecular and functional signature in microglia
  publication-title: Nat. Neurosci.
  doi: 10.1038/nn.3599
  contributor:
    fullname: Butovsky
– volume: 47
  start-page: 169
  year: 1993
  ident: 2023072604113442000_bib16
  article-title: Murine tumor necrosis factor alpha is transported from blood to brain in the mouse
  publication-title: J. Neuroimmunol.
  doi: 10.1016/0165-5728(93)90027-V
  contributor:
    fullname: Gutierrez
– volume: 294
  start-page: 1354
  year: 2001
  ident: 2023072604113442000_bib34
  article-title: CNS synaptogenesis promoted by glia-derived cholesterol
  publication-title: Science.
  doi: 10.1126/science.294.5545.1354
  contributor:
    fullname: Mauch
– volume: 18
  start-page: 800
  year: 2015
  ident: 2023072604113442000_bib35
  article-title: Three dimensions of the amyloid hypothesis: time, space and ‘wingmen’
  publication-title: Nat. Neurosci.
  doi: 10.1038/nn.4018
  contributor:
    fullname: Musiek
– volume: 16
  start-page: 229
  year: 2015
  ident: 2023072604113442000_bib18
  article-title: Innate immunity in Alzheimer’s disease
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.3102
  contributor:
    fullname: Heneka
– volume: 17
  start-page: 263
  year: 1997
  ident: 2023072604113442000_bib3
  article-title: Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition
  publication-title: Nat. Genet.
  doi: 10.1038/ng1197-263
  contributor:
    fullname: Bales
– volume: 96
  start-page: 1024
  year: 2017
  ident: 2023072604113442000_bib32
  article-title: ApoE4 Accelerates Early Seeding of Amyloid Pathology
  publication-title: Neuron.
  doi: 10.1016/j.neuron.2017.11.013
  contributor:
    fullname: Liu
– volume: 91
  start-page: 328
  year: 2016
  ident: 2023072604113442000_bib53
  article-title: TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia
  publication-title: Neuron.
  doi: 10.1016/j.neuron.2016.06.015
  contributor:
    fullname: Yeh
– volume: 195
  start-page: 5
  year: 1995
  ident: 2023072604113442000_bib48
  article-title: ApoE immunoreactivity and microglial cells in Alzheimer’s disease brain
  publication-title: Neurosci. Lett.
  doi: 10.1016/0304-3940(95)11763-M
  contributor:
    fullname: Uchihara
– volume: 8
  start-page: 319
  year: 2014
  ident: 2023072604113442000_bib33
  article-title: Multimodal fluorescence microscopy of prion strain specific PrP deposits stained by thiophene-based amyloid ligands
  publication-title: Prion.
  doi: 10.4161/pri.29239
  contributor:
    fullname: Magnusson
– volume: 368
  start-page: 107
  year: 2013
  ident: 2023072604113442000_bib26
  article-title: Variant of TREM2 associated with the risk of Alzheimer’s disease
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1211103
  contributor:
    fullname: Jonsson
– volume: 21
  start-page: 880
  year: 2015
  ident: 2023072604113442000_bib55
  article-title: Neutrophils promote Alzheimer’s disease-like pathology and cognitive decline via LFA-1 integrin
  publication-title: Nat. Med.
  doi: 10.1038/nm.3913
  contributor:
    fullname: Zenaro
– volume: 100
  start-page: 451
  year: 2000
  ident: 2023072604113442000_bib23
  article-title: Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid beta-peptide deposition in homozygous APP(V717F) transgenic mice
  publication-title: Acta Neuropathol.
  doi: 10.1007/s004010000263
  contributor:
    fullname: Irizarry
– volume: 9
  start-page: 305
  year: 2002
  ident: 2023072604113442000_bib12
  article-title: Human and murine ApoE markedly alters A β metabolism before and after plaque formation in a mouse model of Alzheimer’s disease
  publication-title: Neurobiol. Dis.
  doi: 10.1006/nbdi.2002.0483
  contributor:
    fullname: Fagan
– volume: 90
  start-page: 724
  year: 2016
  ident: 2023072604113442000_bib54
  article-title: TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy
  publication-title: Neuron.
  doi: 10.1016/j.neuron.2016.05.003
  contributor:
    fullname: Yuan
– volume: 77
  start-page: 75
  year: 2015
  ident: 2023072604113442000_bib8
  article-title: Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice
  publication-title: Ann. Neurol.
  doi: 10.1002/ana.24304
  contributor:
    fullname: Butovsky
– volume: 173
  start-page: 6366
  year: 2004
  ident: 2023072604113442000_bib13
  article-title: Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proinflammatory state in apolipoprotein E-deficient mice
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.173.10.6366
  contributor:
    fullname: Grainger
– volume: 37
  start-page: 637
  year: 2017
  ident: 2023072604113442000_bib25
  article-title: Disease progression-dependent effects of TREM2 deficiency in a mouse model of Alzheimer’s disease
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.2110-16.2016
  contributor:
    fullname: Jay
– volume: 213
  start-page: 667
  year: 2016
  ident: 2023072604113442000_bib52
  article-title: TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20151948
  contributor:
    fullname: Wang
– volume: 58
  start-page: 824
  year: 2017
  ident: 2023072604113442000_bib21
  article-title: Apolipoprotein E and Alzheimer’s disease: The influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins
  publication-title: J. Lipid Res.
  doi: 10.1194/jlr.R075481
  contributor:
    fullname: Huynh
SSID ssj0014456
Score 2.6418855
Snippet One of the hallmarks of Alzheimer's disease is the presence of extracellular diffuse and fibrillar plaques predominantly consisting of the amyloid-β (Aβ)...
One of the hallmarks of Alzheimer’s disease is the presence of extracellular diffuse and fibrillar plaques predominantly consisting of the amyloid-β (Aβ)...
Increasing evidence suggests that apoE influences the innate immune response in neurodegeneration. Here, Ulrich et al. report that apoE influences amyloid...
One of the hallmarks of Alzheimers disease is the presence of extracellular diffuse and fibrillar plaques predominantly consisting of the amyloid-beta (A beta)...
SourceID swepub
pubmedcentral
proquest
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 1047
SubjectTerms Apolipoprotein E
Axons
Brain
Deposition
Fluorescence
Fluoroscopic imaging
Gene expression
Immune clearance
Immune response
Immune system
Innate immunity
Metabolism
Mice
Neurodegeneration
Neurodegenerative diseases
Neuroimaging
Neurological diseases
Neurotoxicity
Pathology
Reduction
Rodents
Senile plaques
Toxicity
Transgenic mice
β-Amyloid
Title ApoE facilitates the microglial response to amyloid plaque pathology
URI https://www.ncbi.nlm.nih.gov/pubmed/29483128
https://www.proquest.com/docview/2020477245/abstract/
https://search.proquest.com/docview/2008885505
https://pubmed.ncbi.nlm.nih.gov/PMC5881464
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-150505
Volume 215
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB6SHEIvpWn62DYtCrS9OWvrYUnHJQ9CYEsPTcnNSFopddi1l338_45ke8mSW_FxZCQ-jdAnzacZgG9hpoVigWaUSjygyHyWaRp4prVnznkWRMp4M_1Z3t7zuwfxcABieAuTRPvO1hfNfHHR1H-TtnK5cONBJzb-Nb0UKl5c8fEhHErGhiN6HzrgPJVsTTL1KAHo1e654uMnH9-eF7KgZaxYQzVXrIh12J9vSS945ku55F5S0bQR3byB1z2DJJNupCdw4Ju3cDztY-SncDVZttckGNfl3_ZrghyPLKLw7nGO3kZWnSzWk01LzAIP7PWMLOcGh0NifeJ0z_4O7m-uf1_eZn2thMyJotxk2mqP3MJKLQVyCmQ1FPcnL2wZTARL-4LLYIzNHS5CrYNTknIpvEE-wUrL3sNR0zb-IxCLqzKIMAsuZ9w7q0RgNjBuTWlySekIvg9wVcsuJUaVQtmKV4hwNSA8grMBy6pfGGs00pwjo-doPt-Z0aVjnMI0vt2uU2VMFROtYZsPHfS7joY5G4Hcm5Rdg5gue9-CXpTSZvdeM4If3fTt_XJV_5lU7eqxmtfbCkkyfp_-u4vP8ApBUEngQ8_gaLPa-i_IXTb2a_LVf-pG7d4
link.rule.ids 230,315,733,786,790,891,27957,27958,53827,53829
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwEB4tiwRceD8KCxgJuKVNHDuOj9U-VGC74rC72ltku_ZSSJOqTQ_w6xk7SUXZEyjHceQ445E_ez5_A_DezSTPU0cjSgVuUEQ8iyR1LJLSpsbY1PGgeDM9yyYX7PMVv9oD3t-FCaR9o-fDqlwMq_m3wK1cLsyo54mNvk4Pee4PrtjoFtzGeKWi36R3yQPGQtHWQFT3JICO7x7nbPTd-tvniUho5mvWUMnyNPGV2P9clG4gzZuEyR1Z0bAUnTyAy34QLQPlx3DT6KH59Ze-4z-P8iHc78ApGbfmR7Bnq8dwZ9ql35_A0XhZHxOnTCvtbdcE4SNZeE7fdYkTmaxaxq0lTU3U4mdZz2dkWSocJ_Glj8MR_lO4ODk-P5xEXRmGyPAkayKppUXYooUUHOEKAiaKS5_lOnPKf6G0CRNOKR0bjG8pnckFZYJbhVAlzXT6DParurIvgGgMeMfdzJk4ZdbonLtUu5RplalYUDqAD70fimWrtlGELHnOCnRd0btuAAe9k4ou5tZopDHDzQJD87utGaPFp0BUZevNOhTdzL2GG7Z53vp021E_GQYgdry9beCVuHct6LqgyN25agAf23mx88rR_HJc1KvropxvCsTf-Lz87y7ewt3J-fS0OP109uUV3MMfkgceET2A_Wa1sa8RIjX6TQiI38ceD-k
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb9MwGLVgSBMXfjM6BhgJuKVJHDuOj9W6avzotANDE5fIduxRliZRmx7gr-ezk1Qru0052pHjPH_yc76X9yH0wRaCZYklASEcDig8KgJBLA2EMInWJrHMO97Mz9LTC_rlkl3eKPXlRftaLcZVuRxXi19eW9ksdTjoxMLz-THL3IcrGjaFDe-jBxCzRAwH9T6BQKkv3OrF6k4I0Gveo4yGv437Az3mMUld3RoiaJbErhr7zY3pFtu8LZrcsRb129HsMfo5TKRToVyPN60a67__eTzeaaZP0KOepOJJ1-UpumeqZ2h_3qfhn6PppKlPsJW6s_g2aww0Ei-dtu-qhAWNV53y1uC2xnL5p6wXBW5KCXPFrgSy_5T_Al3MTr4fnwZ9OYZAszhtA6GEAfqiuOAMaAsQJwJboGEqtdI9pTAx5VZKFWmIcyGszjihnBkJlCVJVfIS7VV1ZV4hrCDwLbOF1VFCjVYZs4myCVUylREnZIQ-DljkTee6kftseUZzgC8f4BuhowGovI-9NTSSiMKhgULz-20zRI1LhcjK1Ju1L76ZOS836HPQ4bodaFgQI8R3EN92cI7cuy0An3fm7uEaoU_d2ti5Zbr4Mcnr1VVeLjY58HC4Du88xDu0fz6d5d8-n319jR7C-8i8nIgcob12tTFvgCm16q2PiX9PphJp
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=ApoE+facilitates+the+microglial+response+to+amyloid+plaque+pathology&rft.jtitle=The+Journal+of+experimental+medicine&rft.au=Ulrich%2C+Jason+D.&rft.au=Ulland%2C+Tyler+K.&rft.au=Mahan%2C+Thomas+E.&rft.au=Nystr%C3%B6m%2C+Sofie&rft.date=2018-04-02&rft.pub=Rockefeller+University+Press&rft.issn=0022-1007&rft.eissn=1540-9538&rft.volume=215&rft.issue=4&rft.spage=1047&rft.epage=1058&rft_id=info:doi/10.1084%2Fjem.20171265&rft_id=info%3Apmid%2F29483128&rft.externalDBID=PMC5881464
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1007&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1007&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1007&client=summon